Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

UBLITUXIMAB vs ULIPRISTAL: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

UBLITUXIMAB vs ULIPRISTAL: Safety Overview

Metric UBLITUXIMAB ULIPRISTAL
Total FAERS Reports 1,582 660
Deaths Reported 27 8
Death Rate 1.7% 1.2%
Hospitalizations 213 112
Average Patient Age 49.7 yrs 35.2 yrs
% Female Patients 73.4% 98.1%
FDA Approval Date N/A Aug 13, 2010
Manufacturer TG Therapeutics, Inc. A-S Medication Solutions
Route INTRAVENOUS ORAL
Marketing Status N/A Prescription